Premium
No benefit of an adjunctive phototherapy protocol in treatment of periodontitis: A split‐mouth randomized controlled trial
Author(s) -
Preshaw Philip M.,
Ide Mark,
Bissett Susan M.,
Holliday Richard,
Lansdowne Nichola,
Pickering Kimberley,
Taylor Judy A.,
Levonian Ana M.,
Pleasance Christine,
Guarnelli Maria Elena,
Simonelli Anna,
Fabbri Chiara,
Farina Roberto,
Panagakos Fotinos S.,
Trombelli Leonardo
Publication year - 2021
Publication title -
journal of clinical periodontology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.456
H-Index - 151
eISSN - 1600-051X
pISSN - 0303-6979
DOI - 10.1111/jcpe.13465
Subject(s) - medicine , periodontitis , dentistry , randomized controlled trial , adjunctive treatment , clinical trial , chronic periodontitis , bleeding on probing , gingival and periodontal pocket , surgery
Aim To assess the efficacy of a commercially available adjunctive phototherapy protocol (“Perio‐1”) in treatment of periodontitis. Materials and Methods In an examiner‐blind, randomized, controlled, split‐mouth, multicentre study, 60 periodontitis patients received root surface debridement (RSD) in sextants either alone (control sextants) or with the adjunctive phototherapy protocol (test sextants). Re‐evaluation was performed at 6, 12 and 24 weeks. Results No statistically significant differences in mean (± standard deviation) clinical attachment level (CAL) change from baseline to week 24 were observed between test (−1.00 ± 1.16 mm) and control sextants (−0.87 ± 0.79 mm) at sites with probing pocket depths (PPDs) ≥5 mm (“deep sites”) at baseline ( p = .212). Comparisons between test and control sextants for all other parameters (CAL change at all sites, PPD change at deep sites/all sites, bleeding on probing, plaque scores), and for all change intervals, failed to identify any statistically significant differences. Conclusions The phototherapy protocol did not provide any additional clinical benefits over those achieved by RSD alone. (German Clinical Trials Register DRKS00011229).